Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Prospective, Open-label, Uncontrolled, Phase III Study to Assess the Efficacy and Safety of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery in Subjects With Congenital Fibrinogen Deficiency Octapharma Ongoing Octafibrin 3 Forma 02 KKUH
Prophylactic Acetaminophen (Panadol) To Prevent the Intraventricular Haemorrhage of Premature Babies. King Saud Medical City Rejected Acetaminophen 3 HRC-09-Nov15-02 KSMC
Potential Benefits of Black Seed Oil Supplementation on Asthma Inflammation and Outcomes King Abdulaziz University Hospital Completed Black Cumin Oil 2 95-15 KAUH-J
"Postoperative Analgesic Effect of Dexmedetomidine as an Adjunct to Ropivacaine Administration in Wound Infiltration for Modified Radical Mastectomy- A Randomized controlled Trial" King Abdullah Medical City, Makkah Ongoing DEXMEDETOMIDINE 2 14-119 KAMC
Phase IIIb, Randomized Multicentre Comparative Trial to Evaluate the Long Term Effectiveness & Safety of the use of Carbaglu® in Patients with Propionic Acidemia (PA) or Methylmalonic Acidemia (MMA) KAIMRC Ongoing Carglumic acid 3 IIT-OE-2013-001 NGHA-R
Phase III, Single-arm, Open-label, International, Multi-centre Study to Evaluate the Efficacy and Safety of Lomitapide in Paediatric Patients with Homozygous Familial Hypercholesterolaemia (HoFH) on Stable Lipid-lowering Therapy Amryt Pharmaceuticals DAC Ongoing LOMITAPIDE 3 APH-19 King Abdulaziz Medical City NG (Riyadh)
Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age) Gsk Completed Meningococcal ACWY Conjugate Vaccine 3b 107402 NGHA-R
Phase II/III randomized multicentre study comparing neoadjuvant chemoradiotherapy followed by consolidation chemotherapy to neoadjuvant chemoradiotherapy alone in non-metastatic rectal cancer patients. King Abdullah Medical City, Makkah Ongoing Capecitabine / oxaliplatin / FOLINIC Acid / FLUOROURACIL 2 IRB#17-329 version2 KAMC
Phase II study of the efficacy of metronomic capecitabine chemotherapy as a maintenance treatment in advanced triple negative breast cancer King Abdullah Medical City Ongoing Capecitabine 2 20-611 King Abdullah Medical City (Makkah)
Phase I/II Study of a Lentigen® CD19 Chimeric Antigen Receptor (CAR) T Cells in Adult patients with relapsed/refractory CD19 Positive Non-Hodgkin’s Lymphoma (NHL) using a Closed Transduction System King Faisal Specialist Hospital and Research Centre Completed CD19-CART 1, 2 2191301 KFSH&RC-R
View 291 - 300 From 828